Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000944809-14-000011
Filing Date
2014-08-11
Accepted
2014-08-11 16:48:48
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q opk-6302014x10q.htm 10-Q 1408670
2 EXHIBIT 31.1 opk-6302014xex311.htm EX-31.1 11857
3 EXHIBIT 31.2 opk-6302014xex312.htm EX-31.2 11858
4 EXHIBIT 32.1 opk-6302014xex321.htm EX-32.1 4406
5 EXHIBIT 32.2 opk-6302014xex322.htm EX-32.2 4645
  Complete submission text file 0000944809-14-000011.txt   14139877

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT opk-20140630.xml EX-101.INS 2566582
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT opk-20140630.xsd EX-101.SCH 76831
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT opk-20140630_cal.xml EX-101.CAL 97847
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT opk-20140630_def.xml EX-101.DEF 496991
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT opk-20140630_lab.xml EX-101.LAB 1024779
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT opk-20140630_pre.xml EX-101.PRE 618764
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4138
Opko Health, Inc. (Filer) CIK: 0000944809 (see all company filings)

EIN.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33528 | Film No.: 141031208
SIC: 2834 Pharmaceutical Preparations